Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Mr Enoch Akowuah (James Cook University Hospital, Middlesborough, UK) joins us on-site at ACC's 2023 scientific sessions to discuss the findings of the UK Mini-Mitral trial (National Institute of Health Research).

This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative mitral valve disease. After surgery, patient outcomes were followed up for one year, whilst estimates of clinical and health-economic outcomes will continue to be reported for up to five years.

The trial saw a 96% repair rate in both arms.

Questions:
-What is the importance of the UK Mini Mitral?
-What were the main considerations regarding the design of this trial?
-What were the baseline characteristics of the patients?
-What data did you present at ACC.23?
-How should these findings impact clinical practice?
-What are the next steps?

For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection.

Recorded on-site at ACC 2023, New Orleans.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "ACC 23: Mini-Thoracotomy Vs Sternoctomy for Degenerative Valve Disease: The UK Mini-Mitral Study" передвинте ползунок вправо